FDA Approves Celgene’s Otezla for PsA
The federal Food and Drug Administration has given its nod to Otezla (apremilast) for the treatment of adults with active psoriatic arthritis (PsA).
The federal Food and Drug Administration has given its nod to Otezla (apremilast) for the treatment of adults with active psoriatic arthritis (PsA).
Persana CEO Traci Inglis speaks with Plastic Surgery Practice about how the platform is addressing patient safety concerns by connecting users with board-certified aesthetic physicians in an increasingly unregulated digital landscape.